1 Osteoporosis, Osteomalasia & rickets Bone disorders
2 Thank You for Your comments Voice--- Ok Lecture too long--- this is in schedule??? More interaction--- I can do that inshalla Slides are crowded--- but slides r the ref No short not in exam--- no can do Topics--- unfortunately I don t choose them More S & S--- in therapeutics (dr. hous)
3 Bone function and composition 1. The skeleton provides structural support, 2. protects vital organs & the hematopoietic system, 3. and maintains homeostasis of calcium & other ions. The two types of bone: 1. trabecular (cancellous) 2. and cortical (compact) bone
4 occur in varying amounts at different anatomic sites: Distal radius: 75% cortical and 25% trabecular Lumbar spine: 34% cortical and 66% trabecular Femoral neck: 75% cortical and 25% trabecular Trochanter: 50% cortical and 50% trabecular.
5 Bone function & compestion Trabecular bone is a meshwork of struts giving it a large surface area that is in close contact with the bone marrow cavity for bone turnover and metabolic activity. Cortical bone is formed in layers & is highly calcified (about 80% to 90%). Because of these different structures & environments, trabecular bone is more metabolically active & cortical bone is more structurally strong and protective.
6 Bone function & composition Bone comprises minerals (50-70%), an organic matrix (20-40%), water (5-10%), and lipids (<3%). The predominant mineral is hydroxyapatite [3Ca3(PO4)2(OH)2]. Bone contains 99% of the body s calcium and 85% of its phosphorus.
7 Bone function & composition The organic matrix is primarily protein; 90% type I collagen & 10-15% non collagenous protein and γ -carboxylated proteins; and cells (osteoclasts, osteoblasts, and osteocytes). The mineral provides strength & rigidity while the proteins provide elasticity & flexibility.
8 Bone remodeling and its control The skeleton undergoes constant remodeling throughout life. Peak bone mass is achieved by age years, long after maximum bone length has been achieved. Men achieve higher peak bone mass than women. For 5-10 years after menopause, women have accelerated bone loss, up to 3% per year. Age-related bone loss, about 0.5% per year, begins years after menopause in women & in men at about age 55 years.
9 Bone remodeling & its control Bone is a dynamic tissue. The majority of the skeleton is replaced approximately every 7-10 years. Remodeling repairs microfractures, prepares bone for weight bearing, & provides access to mineral stores. Teams of osteoclasts & osteoblasts, termed basic multicellular units (BMUs), perform this remodeling process. Steps in remodeling are resorption, reversal, formation, and quiescence
10 Bone remodeling & its control This process begins with activation of osteoclasts, causing bone resorption. Osteoclasts attach to bone by an integrin, αvβ3, and create a leakproof seal. The osteoclast s ruffled border secretes acid and proteases, such as H+ & cathepsin K, to dissolve bone.
11 Bone remodeling & its control Osteoclasts create tunnels in cortical bone and pits in trabecular bone. By-products of collagen degradation include hydroxyproline, and N-terminal and C-terminal collagen peptides, which can also serve as biomarkers of resorption. When excavation is complete, reversal begins by osteoclasts undergoing apoptosis or moving to a new section. Resorption takes 3 to 4 weeks.
12 Bone remodeling & its control Formation begins with osteoblasts making osteoid that is mineralized over the ensuing 3 to 4 months. Osteoblasts then either line the bone (lining cells) or become part of the bone as osteocytes. Quiescence follows mineralization
13 Bone remodeling & its control Numerous agents control mesenchymal stem cell derivation and differentiation of osteoblasts Osteoclasts are derived from the myeloid/monocyte cell line with derivation & differentiation also under the control of numerous agents, some of which are expressed from osteoblasts.
14 Bone remodeling & its control A complex array and timing of cytokines and hormones control osteoblasts & osteoclasts during bone remodeling Intensive investigation continues to define the complete process. Although the triggers to begin remodeling are not completely understood, osteocytes may act as mechanosensors, reacting to bone strain & sensing fatigue and damage. Osteocytes communicate with lining cells via a homing signal, which is thought to summon osteoclast precursors to initiate resorption.
15 Bone remodeling & its control Osteoblasts regulate osteoclastic activity by secreting colony-stimulating factors (macrophage colony-stimulating factor [MCSF]; CSF-1) to promote differentiation of osteoclast precursors, receptor activator of nuclear factor κb ligand (RANKL) to promote osteoclast differentiation and maturation, and osteoprotegerin (OPG) to compete with RANKL and prevent osteoclastic differentiation.
16 Bone remodeling & its control Regulation of osteoblast secretion of CSF 1, RANKL, and OPG is complex, involving parathyroid hormone (PTH), 1α-25- dihydroxyvitamin D, leptin, estrogen, and other agents. Transforming growth factor-β (TGF-β), plateletderived growth factor (PDGF), insulin-like growth factor-1 (IGF-1), PTH, growth hormone, & other factors promote bone formation.
17 Bone remodeling & its control Bone mineral density peaks between the ages of 20 & 30 in men and women. Peak bone mass and rate of bone loss is controlled partly by genetics. Under normal conditions in adults, resorption equals formation for no net loss or gain of bone mass. Aging, menopause, & certain diseases & drugs can create an imbalance between formation & resorption & result in bone loss.
18 Serum Ca & Phos Regulation & Vitamin D Metabolism
19 Serum Ca & Phos Regulation & Vitamin D Metabolism Vitamin D and PTH maintain calcium homeostasis. The sun converts 7-dehydrocholesterol in the skin to vitamin D3. Sunscreens inhibit vitamin D skin production. Although a few foods naturally contain vitamin D3 (e.g.,cholecalciferol from fish oils) or vitamin D2 (e.g., ergocalciferol from plants), most dietary intake is from foods fortified with vitamin D.
20 Serum Ca & Phos Regulation & Vitamin D Metabolism Because both vitamin D3 & D2 work similarly in the body, they are referred to here as vitamin D. Vitamin D undergoes hepatic conversion to 25(OH) vitamin D (calcidiol) via D-25-hydroxylase (cytochrome P450 27A1). PTH stimulates renal conversion of 25- hydroxyvitamin D to the active form, 1α-25- dihydroxyvitamin D (calcitriol), via 25(OH)D-1αhydroxylase (cytochrome P450 27B1).
21 Serum Ca & Phos Regulation & Vitamin D Metabolism Decreased serum calcium concentrations lead to increased serum PTH concentrations, which lead to elevated calcitriol concentrations Calcitriol promotes intestinal calcium absorption, & calcitriol & PTH work together to release calcium from bone to restore homeostasis.
22 Serum Ca & Phos Regulation & Vitamin D Metabolism Vitamin D receptors are found in many tissues, such as bone, intestine, brain, heart, stomach, pancreas, lymphocytes, skin, and gonads. Serum phosphorus is less tightly regulated than serum calcium. Excess ingested phosphorus is absorbed and adjusted by the kidney. PTH also controls the kidney set point and decreases renal phosphorus reabsorption.
23 Pathophysiology of osteoporosis
25 Pathophysiology of osteoporosis Osteoporosis is characterized by low bone mass and microarchitectural deterioration of bone tissue leading to enhanced bone fragility and a consequent increase in fracture risk. Bone loss results when resorption exceeds formation. TheWorld Health Organization classifies bone mass based on T-score (number of standard deviations from the mean compared to bone mass of average young women).
26 Pathophysiology of osteoporosis Normal bone mass is defined as a T-score greater than 1, osteopenia as a Tscore of 1 to 2.5, and osteoporosis as a T-score of less than 2.5. In addition to low BMD, high bone turnover, poor bone strength, & impaired bone architecture result in the bone s increased susceptibility to fracture.
27 Pathophysiology of osteoporosis Women with osteopenia have a 1.8-fold increase in fracture rate, & women with osteoporosis have a fourfold increase in fracture rate, compared to women with normal BMD.
28 Pathophysiology of osteoporosis Clinically, osteoporosis is categorized as postmenopausal, age related, or secondary. Postmenopausal osteoporosis affects primarily trabecular bone in the decade following menopause, with fractures occurring predominantly at vertebral & distal forearm sites. Within a few years after peak BMD is attained, usually in the mid- to late-30s, bone loss slowly begins.
29 Pathophysiology of osteoporosis The cumulative effect over time can translate into age-related osteoporosis that affects both cortical and trabecular bone & leads to vertebral, hip, & wrist fractures. Secondary osteoporosis is caused by either diseases or medications & afflicts both bone types. Secondary causes can be found in 11-31% of women & 30-54% of men.
30 Postmenaposal The rate of bone loss commonly accelerates at menopause due to a decline in trophic sex hormone production, especially when a bone healthy lifestyle is not practiced. In older studies, approximately 10-25% of bone loss was documented in the decade after menopause. Bone loss then slows to 8-12% per decade, a rate that was similar to that of older men. This accelerated loss has not been demonstrated in most of the placebo groups who were taking calcium and vitamin D supplements in recently conducted randomized controlled trials.
31 Postmenaposal Estrogen deficiency increases bone resorption more than formation. This process appears to depend on tumor necrosis factor (TNF), interleukin-1 (IL-1), interleukin-11, interleukin-6, MCSF, and prostaglandin E2, which stimulate osteoclastic activity through the OPG/RANK/RANKL system.
32 Postmenaposal Reduced TGF-β, associated with estrogen loss, enhances osteoclast action through decreased apoptosis. Osteocytes also may play a role. Normally, with more weight bearing, osteocytes trigger increased BMD. With menopause, osteocyte apoptosis blunts this response.
33 Age-related Bone resorption increases with age, but changes in bone formation are not observed consistently. Increased osteocyte apoptosis may decrease responses to mechanical strain & hinder bone repair. Cortical porosity from years of remodeling & decreased trabecular connectivity, particularly of horizontal struts, promotes microarchitectural deterioration of bone that is not always reflected in BMD. Aging also increases fracture risk in other ways that are independent of BMD.
34 Age-related Comorbid conditions, cognitive impairment, medications, & deconditioning can increase falls. Inadequate calcium, vitamin D, & nutritional intake also contribute to bone loss & fractures. Vitamin D insufficiency results from poor sun exposure, decreased cutaneous production, insufficient dietary intake, & decreased absorption. Calcium & vitamin D insufficiency promotes secondary hyperparathyroidism & associated bone loss.
36 Men For many reasons, men experience fewer osteoporosis-related fractures than women. Men comprise only approximately 20% of all persons with osteoporosis. This is likely attributable to men attaining a 20-40% higher peak BMD than women & losing BMD at a slower rate after the peak. Men s bones also have a mechanical advantage because the larger bone diameter makes them more fracture resistant.
37 Men Finally, men have a shorter life expectancy and experience fewer falls than women. Male osteoporosis remains an under recognized problem. Although fewer men than women have osteoporosis, men still suffer up to 30% of all hip fractures and are more likely than women to die within 1 year after fracture.
38 Men Hypogonadism, secondary to age-related decreased testosterone and increased sex hormone binding globulin (SHBG), endocrine dysfunction, or androgen ablation, can also cause bone loss. Estrogen, synthesized from testosterone by the enzyme aromatase, appears more important than testosterone in men for bone maintenance, with greater bone density seen in men with higher estradiol concentrations. Secondary causes often contribute to male osteoporosis.
39 Secondary causes Numerous diseases and drugs can decrease bone mass. Secondary causes are suspected when osteoporosis occurs in premenopausal women, men younger than age 70, those with no risk factors, multiple low trauma fractures (especially at a young age), or bone loss despite adequate drug treatment & calcium supplementation. Patients suspected of having secondary causes should undergo careful evaluation that includes a comprehensive physical exam and laboratory assessment. Both the osteoporosis & contributing disorders should be treated.
40 Drug induced Unfortunately, several medications can cause bone loss by a variety of mechanisms. Examples include systemic glucocorticoids, thyroid hormone replacement, some antiepileptic drugs, and heparin use. Thyroid dose adjustment is needed to keep the thyroid-stimulating hormone (TSH) in the upper half of the normal range to minimize bone loss. Some anticonvulsants, like phenobarbital & phenytoin, hasten vitamin D metabolism & the resultant effects can lead to osteomalacia.
41 Drug induced Those at higher risk include people who take multiple anticonvulsants, are institutionalized, or have multiple comorbidities. Heparin therapy, in excess of 15,000 to 30,000 units daily for greater than 3 to 6 months, is associated with bone loss and vertebral fractures. Low-molecular-weight heparins such as enoxaparin may pose less risk of bone loss.
42 Drug induced A black-box warning has been added to the product labeling of medroxyprogesterone acetate injectable contraceptive warning that it significantly decreases bone loss that increases with longer durations of therapy. Thus, this contraceptive product should be used only when other medications prove inadequate.
43 Clinical presentation
46 Introduction Osteomalacia results from defective osteoid mineralization. Defective mineralization in the infant or child produces rickets. In the adult, the syndrome is called osteomalacia.
47 Epidemiology The incidence of osteomalacia is not known precisely, but is lower in the United States because foods are supplemented with vitamin D. Osteomalacia is more prevalent in countries with little sun exposure, minimal dietary supplementation, malnutrition, or traditional clothing covering most of the skin. Dark-skinned individuals synthesize less vitamin D cutaneously & can be at risk for hypovitaminosis D.
48 Pathophysiology Mechanisms leading to osteomalacia include low serum calcium or phosphorus, chronic acidosis, hypophosphatemia, liver or renal disease, and drug-induced mineralization defects.
49 Pathophysiology most common cause is vitamin D deficiency secondary to inadequate intake, decreased sun exposure, malabsorption, or decreased metabolism. Renal disease is associated with decreased 25(OH) vitamin D 1α-hydroxylase, with consequently decreased calcitriol and poor calcium absorption. In vitamin D dependent rickets type I, a genetic defect exists in 25(OH) vitamin D 1α-hydroxylase. Vitamin D dependent rickets type II results from defects in the vitamin D receptor or its activity.
50 Pathophysiology In vitamin D resistant rickets, renal phosphate reabsorption is defective, & 25(OH) vitamin D 1αhydroxylase activity is inadequate. A genetic defect in the PHEX gene may allow inappropriate activity of an undefined inhibitor of phosphate reabsorption that also lowers serum calcitriol concentrations. Pancreatitis, chronic hepatobiliary disease, Crohn s disease, gastrectomy are also risk factors for vitamin D deficiency
51 Pathophysiology Other chronic disorders cause osteomalacia. Phosphate depletion from low dietary intake, phosphate-binding antacids, and oncogenic osteomalacia can cause osteomalacia. Hypophosphatasia is an inborn error of metabolism in which deficient activity of alkaline phosphatase causes impaired mineralization of bone matrix. Acidosis from renal dysfunction, distal renal tubular acidosis, hypergammaglobulinemic states (e.g., multiple myeloma), and drugs (e.g., chemotherapy) compromises bone mineralization.
52 Pathophysiology Renal tubular disorders secondary to Fanconi s syndrome, hereditary diseases (e.g., Wilson s disease, a defect in copper metabolism), acquired disease (e.g., myeloma), and toxins (e.g., lead) cause osteomalacia to varying degrees. Chronic wastage of phosphorus &/or calcium limits mineralization, which may be further compromised by acidosis & secondary hyperparathyroidism.
53 Drug induced Drugs induce osteomalacia through various mechanisms. Phenytoin, primidone, phenobarbital, carbamazepine, rifampin, and some hypnotic medications may cause osteomalacia, potentially through hepatic microsomal cytochrome P450 induction and increased vitamin D metabolism. Anticonvulsant-associated osteomalacia usually occurs only in patients living in an institution or those receiving multiple anticonvulsant drugs. Cholestyramine may decrease vitamin D absorption.
54 Drug induced Defective mineralization can result from continuous or intermittent etidronate treatment or sodium fluoride. Aluminum accumulation in patients with severe renal impairment or in patients undergoing hemodialysis may lead to osteomalacia, potentially through insoluble complexes with phosphates and inhibition of mineral deposition.
55 Clinical presentation Adult osteomalacia often has an insidious presentation. Diffuse skeletal pain, bony tenderness, and proximal muscle weakness may occur. Pain on movement and muscle weakness may result in a characteristic waddling gait. Hypophosphatemia and secondary hyperparathyroidism may contribute to these symptoms. Tetany can result from sufficiently depressed serum ionized calcium. Skeletal deformities (infrequent in adults) include leg bowing, pigeon chest, scoliosis, kyphosis, and shortening of the spine.
56 HW 4 Summaries the pathophysiology of osteomalacia in one page.
The Skeletal Response to Aging: There s No Bones About It! April 7, 2001 Joseph E. Zerwekh, Ph.D. Interrelationship of Intestinal, Skeletal, and Renal Systems to the Overall Maintenance of Normal Calcium
Chapter 6: Osseous Tissue and Bone Structure Functions of the Skeletal System 1. Support 2. Storage of minerals (calcium) 3. Storage of lipids (yellow marrow) 4. Blood cell production (red marrow) 5. Protection
BONE REMODELLING Tim Arnett Department of Anatomy and Developmental Biology University College London The skeleton, out of sight and often out of mind, is a formidable mass of tissue occupying about 9%
Vitamin D: Is it a superhero?? Dr. Ashraf Abdel Basset Bakr Prof. of Pediatrics 1 2 History of vitamin D discovery Sources of vitamin D and its metabolism 13 Actions of vitamin D 4 Vitamin D deficiency
Drugs Affecting Bone Rosa McCarty PhD Department of Pharmacology & Therapeutics firstname.lastname@example.org Objectives At the end of this lecture you should have gained: An understanding of bone metabolism
Pediatric metabolic bone diseases Classification and overview of clinical and radiological findings M. Mearadji International Foundation for Pediatric Imaging Aid www.ifpia.com Introduction Metabolic bone
Overview Osteoporosis and Metabolic Bone Disease Dr Chandini Rao Consultant Rheumatologist Bone Biology Osteoporosis Osteomalacia Paget s Disease Cases Bone Biology Osteoporosis Increased bone remodelling
Who gets Osteoporosis Bone Tested and Why Steve Kane, MD Chairman, AMC Orthopedic Surgery Residency Topics for which I should never be at the podium How I summited Mt. Everest How I found the Titanic My
Chapter 6: Osseous Tissue and Bone Structure I. An Introduction to the Skeletal System, p. 180 Objective: Describe the functions of the skeletal system The skeletal system includes: - bones of the skeleton
BIO 211; Anatomy and Physiology I REFERENCE: CHAPTER 07 1 Dr. Lawrence Altman Naugatuck Valley Community College LECTURE TOPICS OUTLINE SKELETAL SYSTEM I NOTE: LAB ASSIGNMENTS for this topic will run over
Vitamin D Vitamin functioning as hormone Todd A Fearer, MD FACP Vitamin overview Vitamins are organic compounds that are essential in small amounts for normal metabolism They are different from minerals
Ca, Mg metabolism, bone diseases Tamás Kőszegi Pécs University, Department of Laboratory Medicine Pécs, Hungary Calcium homeostasis Ca 1000g in adults 99% in bones (extracellular with Mg, P) Plasma/intracellular
Skeletal System The skeletal System... What are the general components of the skeletal system? What does the skeletal system do for you & how does it achieve these functions? Components The skeletal system
Pathogenesis of Metabolic Bone Disease Stuart M. Sprague, D.O. Chief, Division of Nephrology and Hypertension Professor of Medicine NorthShore University HealthSystem University of Chicago Pritzker School
Effects of Anti RANK ligand Denosumab on Beta Thalassemia induced osteoporosis Mohamed Yassin 1 Ashraf T. Soliman2, Mohamed O. Abdelrahman3, Vincenzo De Sanctis 4 Departments of, 1 Hematology 2Pediatric
The Bare Bones of Osteoporosis Wendy Rosenthal, PharmD Definition A systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, with a consequent increase
Mayo Clin Proc, May 2002, Vol 77 Secondary Causes of Osteoporosis 453 Review Secondary Causes of Osteoporosis LORRAINE A. FITZPATRICK, MD Secondary causes of bone loss are not often considered in patients
BIOH111 o Cell Module o Tissue Module o Integumentary system o Skeletal system o Muscle system o Nervous system o Endocrine system Endeavour College of Natural Health endeavour.edu.au 1 TEXTBOOK AND REQUIRED/RECOMMENDED
Vitamin D & Cardiovascular Disease Disclosures None Vitamin D Objectives: Discuss the basics of vitamin D metabolism Discuss the role of vitamin D deficiency in the development of coronary disease Review
BIO 211: ANATOMY & PHYSIOLOGY I 1 CHAPTER 07 SKELETAL SYSTEM Dr. Lawrence G. G. Altman www.lawrencegaltman.com Some illustrations are courtesy of McGraw-Hill. Some illustrations are courtesy of McGraw-Hill.
Osteoporosis/Fracture Prevention NATIONAL GUIDELINE SUMMARY This guideline was developed using an evidence-based methodology by the KP National Osteoporosis/Fracture Prevention Guideline Development Team
Bone Remodeling Bone Cell Biology David W. Dempster, PhD Professor of Clinical Pathology Columbia University The skeleton, out of site and often out of mind, is a formidable mass of tissue occupying about
Bone Cell Biology David W. Dempster, PhD Professor of Clinical Pathology Columbia University Bone Remodeling The skeleton, out of site and often out of mind, is a formidable mass of tissue occupying about
Men and Osteoporosis So you think that it can t happen to you Jonathan D. Adachi MD, FRCPC Alliance for Better Bone Health Chair in Rheumatology Professor, Department of Medicine Michael G. DeGroote School
From Fragile to Firm Monika Starosta MD Advocate Medical Group Bone Remodeling 10% remodeled each year Calcium homoeostasis Maintain Mechanical strength Replace Osteocytes Release Growth Factors Bone remodeling
Pathogenesis of Metabolic Bone Disease Stuart M. Sprague, D.O. Chief, Division of Nephrology and Hypertension Professor of Medicine NorthShore University HealthSystem University of Chicago Pritzker School
AACE Southern States Chapter Lecture Unusual Bone Cases Basics Osteoporosis Osteomalacia Renal Osteodystrophy Multiple Myeloma 1 Osteoporosis Definition Modeling, Bone Remodeling Bone Resorption > Bone
Vitamin D Replacement ROCKY MOUNTAIN MEETING NOV 2013 BANFF W.COKE UNIVERSITY OF TORONTO Disclosures: (Academic Mea Culpa) No financial conflicts I have no expertise re: Vitamin D. OBJECTIVES: 1) Review
ANATOMY & PHYSIOLOGY 1 (101-805 - AB) PAUL ANDERSON 2011 KEY CONCEPTS Unit 6 THE SKELETAL SYSTEM A Overview of The Skeletal System 1. Definition: Anatomically the SKELETAL SYSTEM consists of bones, cartilages,
Public Health Nutrition: 4(2B), 547±559 DOI: 10.1079/PHN2001140 Calcium and vitamin D nutrition and bone disease of the elderly C Gennari* Institute of Internal Medicine, University of Siena, Italy Abstract
Calcium & Phosphorus Mineral balance and bone physiology Calcium 5th most abundant element on earth Free form is synthesized from CaCl 2 Calcium Adult average: 1100 gr (99% of which is in the bones) Plasma
Calcium metabolism and the Parathyroid Glands Calcium, osteoclasts and osteoblasts-essential to understand the function of parathyroid glands Calcium is an essential element for contraction of voluntary/smooth
Introduction to osteoporosis OBJECTIVES : 1/ Understanding the definition of osteoporosis 2/ Causes of osteoporosis 3/ Impact of osteoporosis 4/ Diagnosis of osteoporosis 5/ Treatment of osteoporosis Editing
Chapter 7 The Skeleton: Bones and Joints The Skeleton Skeletal system is made up of bones and joints and supporting connective tissue. 1. Bone Functions 1. To store calcium salts 2. To protect delicate
Guideline for the investigation and management of osteoporosis for hospitals and General Practice Background Low bone density is an important risk factor for fracture. The aim of assessing bone density
BONE LOSS: HOW TO KEEP BONES STRONG IN THE LONG RUN Bariatric Surgery Support Group 2017 Bones-What s Their Purpose? Structural Function Provides mobility, support and protection for the body Adapts to
Hypercalcemia Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Michael.email@example.com Hypercalcemic Disorders 1 o Hyperparathyroidism Hypercalcemia
Building Bone Density-Research Issues Helping to Regain Bone Density QUESTION 1 What are the symptoms of Osteoporosis? Who is at risk? Symptoms Bone Fractures Osteoporosis 1,500,000 fractures a year Kyphosis
The Impact of Dietary Protein on the Musculoskeletal System Outline A. The musculoskeletal system and associated disorders Jessica D Bihuniak, PhD, RD Assistant Professor of Clinical Nutrition Department
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Osteoporosis/Fracture Prevention Clinician Guide SEPTEMBER 2017 Introduction This Clinician Guide was developed to assist Primary Care physicians
Clinical Practice Management of Osteoporosis Presented by: SaeedBehradmanesh, h MD Internist, Endocrinologist Iran, Isfahan, Feb. 2017 Definition: A disease characterized by low bone mass and microarchitectural
11/4/16 DISCLOSURES Managing the Patient with Osteoporosis Undergoing Spinal Surgery MEDTRONIC LILLY MISONIX SHANE BURCH MD, MS, FRCSC Associate Professor in Residence UCSF Department of Orthopedic Surgery
Joel Johnson, Yr, Subtask, Biology ER., 7/9/5 Osteoporosis The Silent Disease What is Osteoporosis? Osteoporosis is a disease which causes bones to become brittle, which increases the risk of broken bones.
Chapter 6 Chemical Regulation PowerPoint Lectures for Biology: Concepts and Connections, Fifth Edition Campbell, Reece, Taylor, and Simon Testosterone and Male Aggression: Is There a Link? Among male animals,
Diagnosis and Treatment of Osteoporosis Department of Endocrinology and Metabolism Ajou University School of Medicine Yoon-Sok CHUNG WCIM, COEX, Seoul, 27Oct2014 Case 1 71-year old woman Back pain Emergency
Copyright 11 by the Preventive Cardiovascular Nurses Association Promoting Healthy Bones: Sorting Out the Science Guest Speaker Robert P. Heaney, MD, FACP, FASN Professor and Professor of Medicine Creighton
Dr. Chris Doumen Lecture 4 2402 : Anatomy/Physiology Major Endocrine Organs Calci u m H o me os t asis TextBook Readings Pages 624 through 632. Make use of the figures in your textbook ; a picture is worth
Metabolic Bone Disease Related to Chronic Kidney Disease Deborah Sellmeyer, MD Director, Johns Hopkins Metabolic Bone Center Dept of Medicine, Division of Endocrinology Disclosure DSMB member for denosumab
Failure to thrive (faltering growth) Dr. Khalid FTT (faltering growth) The term 'failure to thrive' is a clinical state of growth failure due to any causes, characterized by any one or more of the following
Ch 6 Skeletal System I. Functions of the Skeletal System A. The skeletal system consists of: 1. bones, cartilage, tendons and ligaments B. Living bone is not Gr. dried up 1. It is dynamic and adaptable
Approach to a patient with hypercalcemia Ana-Maria Chindris, MD Division of Endocrinology Mayo Clinic Florida 2013 MFMER slide-1 Background Hypercalcemia is a problem frequently encountered in clinical
Foundations of Orthopaedic Nursing Care, Part Four: Metabolic Bone Disease, highlighting Osteoporosis and Paget s Disease Conflict of Interest I hereby certify that, to the best of my knowledge, no aspect
Metabolic Bone Disease 871 151 Metabolic Bone Disease (Past, Present and Future Challenges in the Management) SNA RIZVI INTRODUCTION The past 40 years have seen some important historical events leading
Changes in Skeletal Systems over the Lifespan Connie M. Weaver, Ph.D. Purdue University Disclosures Boards/Scientific Advisory Committees ILSI Showalter Pharmavite Grants NIH Dairy Research Institute Nestle
Shon E. Meek, M.D., Ph.D. Assistant Professor of Medicine firstname.lastname@example.org 2016 MFMER 3561772-1 Update on Vitamin D Shon Meek MD, PhD 20 th Annual Endocrine Update January 30-Feb 3, 2017 Disclosure Relevant
www.worldosteoporosisday.org LOVE YOUR BONES Protect your future Know your risk for osteoporosis www.iofbonehealth.org Osteoporosis is a problem worldwide, and in many countries, up to one in three women
The discovery of Vitamin D and the elimination of rickets has been considered as one of Medicine s Greatest Achievements. SIR EDWARD MELLANBY 1 8 8 4-1 9 5 5 A D I E T C H A R A C T E R I S T I C O F S
Summary of the risk management plan by product 1 Elements for summary tables in the EPAR 1.1 Summary table of Safety concerns Summary of safety concerns Important identified risks Important potential risks
Bariatric Surgery and Bone Health No conflicts of interest Anne Schafer, MD Assistant Professor of Medicine Division of Endocrinology & Metabolism July 26, 202 BMI and Fracture Risk Low BMI is associated
Focus on CME at the University of Western Ontario Osteoporosis: Not Just for Women Anymore By Lisanne G. Laurier, MD, PhD, FRCPC Osteoporosis is characterized by low bone mass and microarchitectural deterioration
Rooibos tea flavonoids increase mineral content in human osteoblast-like cells Leslie A. Nash, B.Sc. (Honors) Health Sciences Submitted in partial fulfillment of the requirements for the degree of Master
Chapter 26 Hormones and the Endocrine System PowerPoint Lectures for Biology: Concepts & Connections, Sixth Edition Campbell, Reece, Taylor, Simon, and Dickey Copyright 2009 Pearson Education, Inc. Lecture
Hello and welcome. My name is Chad Barnett. I m a Clinical Pharmacy Specialist in the Division of Pharmacy at the University of Texas, MD Anderson Cancer Center and I m very pleased today to be able to
CKD Renal bone disease Dr Mike Stone University Hospital Llandough Affects 5 10 % of population Increasingly common Ageing, diabetes, undetected hypertension Associated with: Cardiovascular disease Premature
Name of Policy: Boniva (Ibandronate Sodium) Infusion Policy #: 266 Latest Review Date: April 2010 Category: Pharmacology Policy Grade: Active Policy but no longer scheduled for regular literature reviews
Calcium, phosphate & magnesium regulation Tim Arnett Department of Cell and Developmental Biology University College London Bone composition Treated with hydrochloric acid to dissolve mineral leaves organic
Sandra Scholten, FNP-BC Discuss burden of osteoporosis (OP) and clinical consequences of OP fractures. Define OP and techniques used to assess bone density and quality. Improve awareness, diagnosis, and
Understanding the Development of Osteoporosis and Preventing Fractures: WHO Do We Treat Now? Steven M. Petak, MD, JD, FACE, FCLM Texas Institute for Reproductive Medicine And Endocrinology, Houston, Texas
hormones HORMONES (Biomedical Importance) Hormones are the chemical messengers of the body. They are defined as organic substances secreted into blood stream to control the metabolic and biological activities.
Hot Topics in Bone Disease in 2017: Building Better Bones Breaking News in Osteoporosis Aromatase Inhibitor-Induced Bone Loss in Early Breast Cancer Rachel Pessah-Pollack, M.D., F.A.C.E. Mount Sinai School
Bone: regulation of development and growth Bone Modeling From: Ham, AW & Cormack, DH. 1987. Ham s Histology. Lippincott, Philadelphia. 1 Bone Remodeling Removal of damaged/aged bone by osteoclasts t (microdamage)
Title Author(s) Citation Issue date 2009-09 Resource Type Resource Version DOI URL Kobe University Repository : Kernel Marked increase in bone formation markers after cinacalcet treatment by mechanisms
VOLUME 6 JUNE/JULY 1993 NUMBER 2 MINERAL IMBALANCE, ENDOCRINES AND HAIR TISSUE MINERAL ANALYSIS ----- David L. Watts, Ph.D., Director of Research ----------------------------------------------------------------------------------------
Human Anatomy and Physiology I Laboratory Skeletal Tissue: Cartilage and Bone This lab involves study of the laboratory exercise Overview of the Skeleton, Classification and Structure of Bones and Cartilages,
Treatment Pattern of Osteoporosis in Bangladesh A dissertation submitted to the Department of Pharmacy, East West University, in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy.
AACE/ACE Osteoporosis Treatment Decision Tool What is Osteoporosis? OSTEOPOROSIS is defined as reduced bone strength leading to an increased risk of fracture. Osteoporosis, or porous bones, occurs when
Instrumental determination of electrolytes in urine Amal Alamri What is the Electrolytes? Electrolytes are positively and negatively chargedions, Found in Within body's cells extracellular fluids, including
26.1 Chemical signals coordinate body functions Chapter 20 Endocrine System! Hormones Chemical signals Secreted by endocrine glands Usually carried in the blood Cause specific changes in target cells Secretory
Business Reminder bone quiz 1 in lab Due in lab Scientific America article summary Priority registration for BI 232 Wednesday 11/14/12 You must fill out a registration form Can t have holds on your account